Jia Xiang
Financieel Directeur/CFO bij HaploX Investment Holding Ltd.
Actieve functies van Jia Xiang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Financieel Directeur/CFO | - | - |
| Bedrijfssecretaris | - | - |
Loopbaan van Jia Xiang
Eerdere bekende functies van Jia Xiang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Hydroelectric Corp. | Corporate Officer/Principal | 01-03-2015 | 01-01-2016 |
Opleiding van Jia Xiang
| Shanghai Jiao Tong University | Graduate Degree |
Statistieken
Internationaal
| China | 2 |
| Verenigde Staten | 2 |
| Hongkong | 2 |
Operationeel
| Director of Finance/CFO | 1 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Hydroelectric Corp. | |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
